ACCESS TO ADVANCED HEALTH INSTITUTE
Federal contract awards won by ACCESS TO ADVANCED HEALTH INSTITUTE (UEI EMQ1ANLATYS6), 2014–2023 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
6
awards
0
expiring in 12 months
1
agency
Teaming snapshot
primes 6 subs.
From subcontract reports primes file with USAspending/FSRS.
Where their reported work happens
| State | Reported subawards |
|---|---|
| IN | 1 |
| CO | 1 |
| GA | 1 |
| IL | 1 |
| CA | 1 |
| WI | 1 |
Place of performance on subcontract reports filed with USAspending/FSRS.
Category award history
4 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: REGENTS OF THE UNIVERSITY OF MICHIGAN took Department of Health and Human Services 541714 work from INFECTIOUS DISEASE RESEARCH INSTITUTE (Aug 31, 2026).
Agencies buying from ACCESS TO ADVANCED HEALTH INSTITUTE
What ACCESS TO ADVANCED HEALTH INSTITUTE has provided
541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (3)325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (1)541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) (1)541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (1)
Awards
BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES
Department of Health and Human Services · $1,236,651 · Jul 5, 2023
INFECTIOUS DISEASE RESEARCH INSTITUTE: R&D OF INTRANASAL ADMINISTRATION OF RNA VACCINES AGAINST RESPIRATORY PATHOGENS
Department of Health and Human Services · $748,885 · Sep 20, 2021
INVESTIGATIONAL PRODUCTS GLA-SE ADJUVANT FORMULATION AND LYOPHILIZED ID93 FROM IDRI FOR DAIDS-FUNDED CLINICAL TRIALS
Department of Health and Human Services · $780,764 · Sep 3, 2021
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Department of Health and Human Services · $13,771,809 · Sep 9, 2019
IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.
Department of Health and Human Services · $10,833,357 · Sep 21, 2018
IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
Department of Health and Human Services · $11,573,495 · Jul 23, 2014